The Global Preclinical In-vivo Imaging Market is expected to grow at a CAGR of 6% during the forecasting period (2022-2029).
Preclinical in-vivo imaging is used in live animal research for drug development. Preclinical imaging is also used to monitor the treatment response for the early indications of efficacy. The presence of technological development of in vivo imaging allows for studying the disease at the molecular level in a quantitative way.
Download Sample Brochure @ https://www.datamintelligence.com/download-sample/preclinical-in-vivo-imaging-market
The global preclinical in-vivo imaging market is driven by technological advancements in imaging modalities, increasing demand for non-invasive small animal imaging techniques, a rise in preclinical research funding by both private and public organizations, and an increasing prevalence of chronic diseases.
The growing prevalence of chronic diseases such as cancer, cardiovascular, rheumatoid arthritis, neurological disorders, and other diseases are expected to boost the market over the period of forecast. For instance, the WHO has reported that cancer is the second leading cause of death globally and is responsible for 9.6 million deaths in 2018 and worldwide, about 1 in 6 deaths is only because of cancer. Also, around 70% of deaths from cancer occur in low and middle-income countries. WHO stated that around 17.9 million people die each year from cardiovascular diseases, and globally, it accounts for 31% of deaths.
The presence of technological developments in imaging is expected to drive the market. For instance, “Aspect’s M2,” a preclinical imaging product developed by Aspect imaging, is used for drug development. Also, newer technologies like photoacoustic tomography and confocal laser endomicroscopy lend the ability to identify critical and highly specific biomarker information for oncology, immunology, and neurology strategies. These approaches are expected to enhance preclinical and translational research significantly.
The presence of innovative product launches related to preclinical in-vivo imaging is expected to drive the market. For instance, in 2018, next-generation SPECT cameras with cadmium zinc telluride (CZT) detectors can reduce the patient radiation dose and shortens the examination time.
Increasing funding for preclinical research is also expected to boost the market. For instance, in 2017, the Alzheimer’s Drug Discovery Foundation (ADDF) accepted Letters of Intent which filled the translational funding gap between research and later-stage drug development by funding preclinical drug discovery. Also, it has provided funding up to USD 5 million for preclinical studies. In 2015 the Deutsches Zentrum fur Herz-Kreislaufforschung e.V. (DZHK) has provided Euro 6 million for the preclinical research projects.
However, with the high installation and operational costs of preclinical imaging modalities, stringent regulations are likely to hamper the market.
- Optical Imaging Systems
- Preclinical Nuclear Imaging Systems
- Micro-MRI Systems
- Micro-Ultrasound Systems
- Micro-CT Systems
- Preclinical Optical Imaging Reagents
- Preclinical Nuclear Imaging Reagents
- Preclinical MRI Contrast Agents
- Preclinical Ultrasound Contrast Agents
- Preclinical CT contrast agents
The key players operating in the global preclinical in-vivo imaging market are Bruker Corporation, Siemens A.G., TriFoil Imaging, PerkinElmer, VisualSonics Inc. (Fujifilm), MILabs B.V., Mediso Ltd., and Agilent Technologies.
The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the preclinical in-vivo imaging market globally. For instance,
On June 8, 2018, MILabs launched the E-Class line of high-performance, economical PET, SPECT, and CT systems.
On June 12, 2018, Bruker launched the SKYSCAN 2214, a multiscale X-ray nano-CT system with a unique X-ray source with outstanding precision.
Diagnostic Imaging Equipment Market
Dental Imaging Equipment Market
DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision-making in designing disruptive solutions.
Name: Sai Kiran
Company: DataM Intelligence
Contact No: +1 8774414866
Email us: email@example.com